AMAG Pharmaceuticals, Inc. (AMAG) Tops Q4 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Product sales, net: 115.78M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Product sales, net: 115.78M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q4 EPS of ($0.87), $0.25 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.72 million.
For earnings history and earnings-related data on AMAG Pharmaceuticals, Inc. (AMAG) click here.
For earnings history and earnings-related data on AMAG Pharmaceuticals, Inc. (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Red Rock Resorts (RRR) PT Lowered to $60 at StoneX
- McDonald's shares gain as profit tops expectations despite revenue miss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
